| Ms Maureen Elizabeth Shelley, PHARMD | |
|
1212 Pico St Rm 141, San Fernando, CA 91340-3503 | |
| (818) 627-4744 | |
| Not Available |
| Full Name | Ms Maureen Elizabeth Shelley |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Ambulatory Care |
| Location | 1212 Pico St Rm 141, San Fernando, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619580909 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P2201X | Pharmacist - Ambulatory Care | 68107 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Maureen Elizabeth Shelley, PHARMD 3457 Lily Ct, Newbury Park, CA 91320-2023 Ph: (805) 208-1212 | Ms Maureen Elizabeth Shelley, PHARMD 1212 Pico St Rm 141, San Fernando, CA 91340-3503 Ph: (818) 627-4744 |
News Archive
In this work, Dr. Diana and fellow researchers propose a low cost technique able to produce microfluidic devices for biomedical applications. The most common technique to fabricate biomedical microdevices is soft-lithography. However, it is a costly and time-consuming technique. Progress in manufacturing milling tools smaller than 100 µm, has enabled the use of micromilling machines to fabricate microfluidic devices capable of performing cell separation.
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A new study led by researchers at Boston Medical Center indicates that variations in opioid receptor genes are associated with more severe neonatal abstinence syndrome (NAS) in newborn babies. The findings, published online in Drug & Alcohol Dependence, could help lead to the development of individualized treatment plans tailored to each infants' risk of requiring medication to curb their NAS symptoms, which could help improve these patients' outcomes and reduce how long some stay in the hospital.
Obesity is a growing epidemic in the U.S. with a significant increase in prevalence from 15 percent to 32.9 percent from 1980 to 2004. Nonalcoholic fatty liver disease (NAFLD) is an emerging problem related to the obesity epidemic, becoming one of the most common causes of liver disease in the nation.
› Verified 4 days ago
Kamila Rezaei Seisan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11234 Laurel Canyon Blvd, San Fernando, CA 91340 Phone: 818-617-2207 | |
Ka Ming Yue, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1204 San Fernando Rd, San Fernando, CA 91340 Phone: 818-361-2679 | |
Javier Garcia, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1204 San Fernando Rd, San Fernando, CA 91340 Phone: 818-361-2679 | |
Larisa Gorelik, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 San Fernando Rd, San Fernando, CA 91340 Phone: 818-365-8086 Fax: 818-365-8095 | |
Sung Jin Kim, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14727 Rinaldi St, San Fernando, CA 91340 Phone: 818-361-8010 | |
Dr. Tereza Elen Nersesian, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11273 Laurel Canyon Blvd Ste 4, San Fernando, CA 91340 Phone: 818-638-9652 | |
Dr. Jennifer J Chen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1431 Truman St Ste M, San Fernando, CA 91340 Phone: 818-660-0321 |